跳至主要内容
临床试验/NCT02422277
NCT02422277Unknown2 期

Role of Low-intensity Shock Wave Therapy in Penile Rehabilitation Post Nerve Sparing Radical Cysto-prostatectomy

Mansoura University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2015年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
入组人数
60
试验地点
1
主要终点
Improvement of sexual function by increase satisfaction and good vaginal penetration

研究概览

简要总结

The aim of this clinical trial is to evaluate the role of extracorporeal low-intensity shock wave therapy in penile rehabilitation post nerve sparing radical cysto-prostatectomy.

详细描述

60 patients for whom nerve sparing radical cystoprostatectomy will be carrried out, penile rehabilitation by using low intensity extracorporeal shock wave therapy will be applied in 20 patients, another 20 patients will receive oral phosphodiestrase type 5 inhibitorrs and 20 patients will not receive any interventions in the control group.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
30 Years 至 75 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Patients will be eligible if he is sexually motivated and potent men with stable relationship of more than 6 months duration who will undergo nerve sparing radical cysto-prostatectomy for organ-confined bladder cancer.

排除标准

  • Men with Peyronie's disease.
  • Inflammation in the shock wave area.
  • Evidence of disease failure after surgery.
  • Patients developing postoperative complications requiring hospital readmission after surgery which interferes with the process of SWL.
  • Unstable medical or psychiatric disorder.

研究组 & 干预措施

LI-ESWT group

Active Comparator

Intervention include that patients will undergo penile low-intensity extracorporeal shock wave therapy, 6-12 sessions, 1500 shocks per session, two sesssions per week for 3 weeks then 3 weeks break and then 2 sessions per week for 3 weeks.

干预措施: LI-ESWT group (Device)

PDE-5 inhibitors group

Active Comparator

Intervention include that patients will intke oral tablets of PDE-5 inhibitors :

  • Oral intake of 50 mg once daily for 6 months.

干预措施: PDE-5 inhibitors group (Drug)

结局指标

主要结局

Improvement of sexual function by increase satisfaction and good vaginal penetration

时间窗: 6 MOTHES

increase in IIEF score by 5 degrees

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Tamer Zewin

Clinical Fellow in Urology and Nephrology center, Faculty of Medicine, Mansoura University

Mansoura University

研究点 (1)

Loading locations...

相似试验